Key Highlights
- Cannabis refers to a group of three psychoactive plants: Cannabis sativa, Cannabis indica, and Cannabis ruderalis. Our market scope includes both recreational and medicinal uses of cannabis, which are governed by regulated operations. This encompasses licensing, taxation, and strict adherence to safety standards. Market value refers to revenue generated by market players in a specific year.
- The Middle East & African cannabis market recorded revenues of $2.99 billion in 2024, representing a compound annual growth rate (CAGR) of 27.2% between 2019 and 2024.
- The medical use segment accounted for the market's largest proportion in 2024, with total revenues of $1.70 billion, equivalent to 56.8% of the market's overall value.
- South Africa accounted for a share of 4.2% of the Middle East & African cannabis market in 2024.
Scope
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the cannabis market in Middle East & Africa
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the cannabis market in Middle East & Africa
- Leading company profiles reveal details of key cannabis market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Middle East & Africa cannabis market with five year forecasts
Reasons to Buy
- What was the size of the Middle East & Africa cannabis market by value in 2024?
- What will be the size of the Middle East & Africa cannabis market in 2029?
- What factors are affecting the strength of competition in the Middle East & Africa cannabis market?
- How has the market performed over the last five years?
- What are the main segments that make up Middle East & Africa's cannabis market?
Table of Contents
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Canopy Growth Corp
- MG Health Ltd
- Tilray Brands Inc

